NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

4 hedge funds and large institutions have $469 invested in Navidea Biopharmaceuticals Inc. in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$435
2 +$14

Top Sellers

1 -$41.9K
2 -$37K
3 -$33.1K
4
VF
Virtu Financial
New York
-$30K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$24.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$435
2
$19
3
$14
4
$1
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25